Viking Global Investors LP Teva Pharmaceutical Industries LTD Transaction History

Viking Global Investors LP

  • $35.2 Billion
  • Q3 2025

A detailed history of Viking Global Investors LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Viking Global Investors LP holds 2,532,119 shares of TEVA stock, worth $64.3 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,532,119
Previous 11,681,333 78.32%
Holding current value
$64.3 Million
Previous $196 Million 73.87%
% of portfolio
0.15%
Previous 0.62%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$15.38 - $20.2 $141 Million - $185 Million
-9,149,214 Reduced 78.32%
2,532,119 $51.1 Million
Q2 2025

Aug 14, 2025
BUY
$12.82 - $18.15 $19.9 Million - $28.2 Million
1,555,855 Added 15.37%
11,681,333 $196 Million
Q1 2025

May 15, 2025
BUY
$14.67 - $22.01 $53.1 Million - $79.7 Million
3,621,993 Added 55.69%
10,125,478 $156 Million
Q4 2024

Feb 14, 2025
SELL
$16.43 - $22.77 $17.5 Million - $24.2 Million
-1,064,048 Reduced 14.06%
6,503,485 $143 Million
Q3 2024

Nov 14, 2024
BUY
$15.81 - $18.96 $120 Million - $143 Million
7,567,533 New
7,567,533 $136 Million
Q4 2016

Feb 14, 2017
SELL
N/A
-19,684,219 Closed
0 $0
Q3 2016

Nov 14, 2016
SELL
N/A
-8,052,436 Reduced 29.03%
19,684,219 $906 Million
Q2 2016

Aug 15, 2016
SELL
N/A
-5,234,967 Reduced 15.88%
27,736,655 $1.39 Billion
Q1 2016

May 16, 2016
BUY
N/A
7,927,847 Added 31.66%
32,971,622 $1.76 Billion
Q4 2015

Feb 16, 2016
BUY
N/A
16,171,125 Added 182.26%
25,043,775 $1.64 Billion
Q3 2015

Nov 16, 2015
BUY
N/A
8,872,650 New
8,872,650 $501 Million
Q2 2015

Aug 14, 2015
SELL
N/A
-228,600 Closed
0 $0
Q1 2015

May 15, 2015
BUY
N/A
228,600
228,600 $14.2 Million

Others Institutions Holding TEVA

# of Institutions
669
Shares Held
624M
Call Options Held
30.8M
Put Options Held
18.5M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $28.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Viking Global Investors LP Portfolio

Follow Viking Global Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Viking Global Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email